All the news Showing 10 of 15 articles from: CirrhosisGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources People with liver cirrhosis have weaker responses to the Pfizer and Moderna SARS-CoV-2 vaccines Keith Alcorn / 16 November 2021 People with cirrhosis of the liver had delayed and suboptimal responses to the Pfizer or Moderna SARS-CoV-2 vaccines compared to healthy adults, an Italian study has found. People with decompensated cirrhosis had significantly ... US doctors failing to diagnose hepatitis C years after first signs of cirrhosis Keith Alcorn / 23 August 2019 Doctors are failing to test for hepatitis C in up to one in five people who have advanced liver disease despite many years of medical care, and these people are more likely ... Faecal transplants improve encephalopathy in people with advanced liver disease Liz Highleyman / 24 April 2019 Faecal microbiota transplantation (FMT), which helps restore a healthy mix of bacteria in the gut, can help reverse brain function impairment in people with liver failure, according to a report at the International ... What support do people with liver cirrhosis and their families need? Keith Alcorn / 09 October 2018 People with liver cirrhosis and their families need more information about their condition and prognosis and greater access to palliative care, a systematic review of studies on the needs of people with cirrhosis ... Fibroscan finds one in six people with hepatitis C in primary care have advanced liver disease Keith Alcorn / 28 August 2018 Measuring liver stiffness in primary care using Fibroscan is feasible and detects numerous cases of undiagnosed but advanced liver fibrosis, Australian researchers report in the journal BMJ Open this month. Despite availability of direct-acting ... Hepatitis C treatment highly effective in harder-to-treat people with HIV co-infection, Spanish real-life study shows Michael Carter / 16 January 2018 Hepatitis C virus (HCV) treatment using direct-acting antivirals (DAAs) is highly effective and safe in harder-to-treat people with HIV co-infection, Spanish researchers report in AIDS. A sustained virological response (SVR), ... Statins reduce risk of decompensation for people with HCV- and HBV-related cirrhosis Michael Carter / 18 April 2017 Treatment with statins reduces the risk of decompensated liver disease for people with cirrhosis caused by hepatitis B virus (HBV) and hepatitis C virus (HCV), investigators from Taiwan report in the online edition ... Curing hepatitis C reduces liver-related complications and death Liz Highleyman / 23 January 2017 People with hepatitis C who achieve sustained virological response to treatment had lower liver-related morbidity and mortality rates compared to people who were not successfully treated, according to research presented at the 2016 ... Improvements in HIV treatment and care have had no impact on rates of endstage liver disease among HIV-positive people with viral hepatitis Michael Carter / 01 September 2016 Incidence of endstage liver disease (ESLD) among HIV-positive people with viral hepatitis changed little between 1996 and 2010, despite major improvements in HIV treatment and care, investigators from Canada and the United States ... Statins reduce risk of progression to cirrhosis in people with HIV/HCV co-infection Michael Carter / 30 August 2016 Treatment with statins decreases the risk of progression to liver cirrhosis in people with HIV/hepatitis C virus (HCV) co-infection, investigators from the United States report in AIDS. The protective effect of statins was ... ← First12Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive